4T1 Syngeneic Murine Model - Altogen Labs
Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model | Nature Communications
Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model: Molecular Therapy
Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response - ScienceDirect
Rejection of Metastatic 4T1 Breast Cancer by Attenuation of Treg Cells in Combination With Immune Stimulation: Molecular Therapy
Mouse 4T1 Breast Tumor Model - Pulaski - 2000 - Current Protocols in Immunology - Wiley Online Library
Imagable 4T1 model for the study of late stage breast cancer | BMC Cancer | Full Text
Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response - ScienceDirect
In vivo orthotopic breast tumor model - by Explicyte Immuno-Oncology
JCI Insight - Metastasis regulation by PPARD expression in cancer cells
Frontiers | Comparative Profiling of Metastatic 4T1- vs. Non-metastatic Py230-Based Mammary Tumors in an Intraductal Model for Triple-Negative Breast Cancer
Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model | Nature Communications
Marizomib inhibit tumor growth in syngeneic 4T1.2 murine model of TNBC... | Download Scientific Diagram
Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model | Nature Communications
Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist | PNAS
Local angiotensin II contributes to tumor resistance to checkpoint immunotherapy | Journal for ImmunoTherapy of Cancer
CT26 Syngeneic Mouse Model - Altogen Labs
In vivo orthotopic breast tumor model - by Explicyte Immuno-Oncology
CC inhibits in vivo tumor growth and lung metastasis in 4T1-syngeneic... | Download Scientific Diagram
Diindolylmethane Promotes Metabolic Crisis and Enhances the Efficacy of Centchroman in Breast Cancer: A 1H NMR-Based Approach | ACS Omega
Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer | Journal of Experimental & Clinical Cancer Research | Full Text
OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer | npj Breast Cancer
Frontiers | 4T1 Mammary Carcinoma Colonization of Metastatic Niches Is Accelerated by Obesity
Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis | Anticancer Research
